Selective vulnerability in α-synucleinopathies-Reference-Cited by-同舟云学术

Selective vulnerability in α-synucleinopathies

Published:2019-04-20 Issue:5 Volume:138 Page:681-704
ISSN:0001-6322
Container-title:Acta Neuropathologica
language:en
Short-container-title:Acta Neuropathol

Author:

Alegre-Abarrategui Javier^ORCID,Brimblecombe Katherine R.,Roberts Rosalind F.,Velentza-Almpani Elisavet,Tilley Bension S.,Bengoa-Vergniory Nora,Proukakis Christos

Funder

NIHR Imperial Biomedical Research Centre

Jean Shanks Foundation

National Institute on Aging

Parkinson’s UK

Michael J. Fox Foundation for Parkinson's Research

Network of Centres of excellence in Neurodegeneration

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00401-019-02010-2.pdf

Reference191 articles.

1. Aamodt AH, Stovner LJ, Thorstensen K, Lydersen S, White LR, Aasly JO (2007) Prevalence of haemochromatosis gene mutations in Parkinson’s disease. J Neurol Neurosurg Psychiatry 78:315–317. https://doi.org/10.1136/jnnp.2006.101352

2. Abeyawardhane DL, Fernandez RD, Murgas CJ, Heitger DR, Forney AK, Crozier MK et al (2018) Iron redox chemistry promotes antiparallel oligomerization of alpha-synuclein. J Am Chem Soc 140:5028–5032. https://doi.org/10.1021/jacs.8b02013

3. Acosta SA, Tajiri N, de la Pena I, Bastawrous M, Sanberg PR, Kaneko Y et al (2015) Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson’s disease. J Cell Physiol 230:1024–1032. https://doi.org/10.1002/jcp.24830

4. Acosta SA, Tajiri N, Shinozuka K, Ishikawa H, Grimmig B, Diamond DM et al (2013) Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model. PLoS One 8:e53376. https://doi.org/10.1371/journal.pone.0053376

5. Alegre-Abarrategui J, Ansorge O, Esiri M, Wade-Martins R (2008) LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson’s disease. Neuropathol Appl Neurobiol 34:272–283. https://doi.org/10.1111/j.1365-2990.2007.00888.x

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell spatial transcriptomics reveals molecular patterns of selective neuronal vulnerability to α-synuclein pathology in a transgenic mouse model of Lewy body disease;2024-08-01

2. Alpha Synuclein Toxicity and Non-Motor Parkinson’s;Cells;2024-07-27

3. Cognitive dysfunction in animal models of human lewy-body dementia;Frontiers in Aging Neuroscience;2024-07-22

4. Aging disrupts the coordination between mRNA and protein expression in mouse and human midbrain;2024-06-01

5. Focusing on mitochondria in the brain: from biology to therapeutics;Translational Neurodegeneration;2024-04-17